Scientists create LED light that kills cancer cells without harming healthy ones
- byDoctor News Daily Team
- 27 October, 2025
- 0 Comments
- 0 Mins
Scientists have developed a promisingcancer therapythat uses LED light and ultra-thin flakes of tin to eliminatecancercells while protecting healthy tissue. Unlike traditionalchemotherapyand other invasive treatments, this new method avoids the painful side effects patients often endure. The breakthrough comes from a partnership between The University of Texas at Austin and the University of Porto in Portugal, made possible through the UT Austin Portugal Program. The collaboration aims to make light-based cancer therapies more accessible and affordable. Current versions of these treatments rely on expensive materials, specialized lab setups, and powerful lasers that can sometimes damage surrounding tissue. By switching to LEDs and introducing tin-based "SnOx nanoflakes" ("Sn" is the chemical symbol for tin), the researchers have created a safer and potentially low-cost alternative. "Our goal was to create a treatment that is not only effective but also safe and accessible," said Jean Anne Incorvia, a professor in the Cockrell School of Engineering's Chandra Family Department of Electrical and Computer Engineering and one of the leaders on the project. "With the combination of LED light and SnOx nanoflakes, we've developed a method to precisely target cancer cells while leaving healthy cells untouched." In a recent study published in ACS Nano, the approach proved highly effective against both colorectal and skin cancer cells. After only 30 minutes of exposure, the LED-driven treatment destroyed up to 92% of skin cancer cells and 50% of colorectal cancer cells, while leaving healthy human skin cells unharmed. The results highlight the therapy's precision and safety. Cancer remains the second-leading cause of death worldwide, and many existing treatments come with severe side effects. Scientists across the globe are exploring new methods to make therapies safer and more targeted. One of the most promising is near-infrared photothermal therapy, which uses light to heat and destroy cancer cells without the need for surgery or toxic drugs. This principle forms the foundation of the UT Austin-Portugal team's research. Having shown strong early results, the researchers are now focused on understanding how light and heat interact in the process and on testing other materials that might enhance the treatment. They also plan to design practical medical devices that can deliver the therapy directly to patients. "Our ultimate goal is to make this technology available to patients everywhere, especially places where access to specialized equipment is limited, with fewer side effects and lower cost," said Artur Pinto, a researcher at the Faculty of Engineering of the University of Porto and lead researcher of the project in Portugal. "For skin cancers in particular, we envision that one day, treatment could move from the hospital to the patient's home. A portable device could be placed on the skin after surgery to irradiate and destroy any remaining cancer cells, reducing the risk of recurrence." Incorvia and Pinto first teamed up through the UT Austin Portugal Program in 2021. Since then, they have exchanged visits between Texas and Portugal and combined their expertise to explore how two-dimensional materials can be used to advance cancer therapies. Building on their success, the team recently received additional funding through the UT Austin Portugal Program to create an implant for breast cancer patients using the same LED and nanoflake technology. Their continued collaboration could pave the way for more personalized, affordable, and pain-free cancer treatments in the near future. Hui-Ping Chang, Filipa A. L. S. Silva, Eva Nance, José R. Fernandes, Susana G. Santos, Fernão D. Magalhães, Artur M. Pinto, Jean Anne C. Incorvia. SnOx Nanoflakes as Enhanced Near-Infrared Photothermal Therapy Agents Synthesized from Electrochemically Oxidized SnS2 Powders. ACS Nano, 2025; 19 (38): 33749 DOI: 10.1021/acsnano.5c03135
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
Recent News
NEET 2025: TN Health extends round 3 choice fillin...
- 31 October, 2025
DME Gujarat extends PG Ayurveda, Homeopathy round...
- 31 October, 2025
Decade-Long Study of PCI and CABG in Left Main Cor...
- 31 October, 2025
AI-Powered ECG Interpretation Found Better than St...
- 31 October, 2025
Daily Newsletter
Get all the top stories from Blogs to keep track.
0 Comments
Post a comment
No comments yet. Be the first to comment!